CDKN1A and cancer: lncRNA-p21 reduces cancer cell survival and self-renewal capacity and promotes cancer cell glycolysis via inhibiting the β-catenin signal to inhibit CRC cells with stem cell-like features from developing into mature cancer cells [50].